Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress-Reference-Cited by-同舟云学术

Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress

Published:2021-08 Issue:8 Volume:26 Page:1857-1874
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Yao Hang-Ping,Zhao Hui,Hudson Rachel,Tong Xiang-Min,Wang Ming-Hai

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference88 articles.

1. Antibody-drug conjugates: a comprehensive review;Khongorzul;Mol. Cancer Res.,2020

2. FDA approves antibody-directed cytotoxic agent for acute myeloid leukemia;Miller;Am. J. Health Syst. Pharm.,2000

3. Pharmacokinetic/pharmacodynamic modeling to support the re-approval of gemtuzumab ozogamicin;Fostvedt;Clin. Pharmacol. Ther.,2019

4. Brentuximab vedotin for treatment of non-Hodgkin lymphomas: a systematic review;Berger;Crit. Rev. Oncol. Hematol.,2017

5. FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer;Amiri-Kordestani;Clin. Cancer Res.,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical innovation and advanced biotechnology in the biotech-pharmaceutical industry for antibody–drug conjugate development;Drug Discovery Today;2024-08

2. Implementation of antibody-drug conjugates in HER2-positive solid cancers: Recent advances and future directions;Biomedicine & Pharmacotherapy;2024-05

3. Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates;Pharmacological Reviews;2024-04-15

4. Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro;International Journal of Molecular Sciences;2024-04-14

5. DNA Adducts in Cancer Chemotherapy;Journal of Medicinal Chemistry;2024-03-29